Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Colorectal cancer (CRC) is the 3rd most commonly diagnosed cancers worldwide. Due to low compliance to and low accuracy of existing screening tools, many CRC-s are still discovered in the late stage, resulting in high mortality rates. Capture of ctDNA methylation signals through Highly Multiplexed Targeted Bisulfite Sequencing, combined with computational biology and machine learning approaches offers a timely, accurate and non-invasive option for early cancer diagnosis, leading to improved treatment outcomes.